Skip to main content
. 2015 Jun 26;21(5):428–434. doi: 10.5152/dir.2015.14306

Table 3.

Third quartile dose length product (mGy.cm) results for adult and pediatric patients from Turkey (n=25) and other countries

Adult examinations Turkey 2014 Syria (18) 2009 Italy (22) 2014 UK (17) 2003 Ireland (20) 2012 EC (21) 2011
 Head 810 793 1312 760 940 733
 Chest 289 520 569 430 393 394
 HRCT-chest 283 133 - 80 276 -
 Abdominal 204 721 555 510 598 464
 Pelvic 421 542 360 - 598 434
Pediatric examinations <1 year 1–5 years 5–10 years 10–15 years
 Head (Turkey) 288 368 467 625
 Head (Kenya) (19) 270 470 620 620
 Head (Germany) (30) 250 450 650 700
 Head (Switzerland) (26)* 213 332 451 805
 Chest (Turkey) 181 214 277 287
 HRCT-chest (Turkey) 137 199 277 265
 Chest (Kenya) (19) 6 6.5 10 -
 Chest (Germany) (30) - 100 300 800
 Chest (Switzerland) (26)* 85 161 178 366
 Abdominal (Turkey) 104 125 179 210
 Abdominal (Germany) (30) - 150 400 750
 Abdominal (Switzerland) (26)* 107 238 308 398
 Pelvic (Turkey) 128 164 242 241

UK, United Kingdom; EC, European Commission; HRCT-chest, high-resolution computed tomography of the chest.

*

Reference 26 reported mean values instead of third quartiles.